---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-018380"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2023-05-19T23:59:59+00:00"
generated_at: "2026-06-14T20:31:31.253216+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Oncotelic adopts new bylaws with advance notice provisions for shareholder proposals.

## Summary
- Board adopted new amended and restated bylaws on May 18, 2023.
- New bylaws add advance notice requirements for shareholder proposals at meetings or consent solicitations.
- Replaces prior bylaws; full text filed as Exhibit 3.2.
- No financial or operational changes reported.

## SEC filing metadata
- accession: 0001493152-23-018380
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2023-05-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315223018380/0001493152-23-018380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315223018380/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-018380
- JSON: https://secwatch.observer/filing/0001493152-23-018380.json
- Plain text: https://secwatch.observer/filing/0001493152-23-018380.txt

## Key facts
- Governance Changes
  Oncotelic Therapeutics, Inc.: Adopted new amended and restated by-laws containing new advance notice provisions for shareholder proposals and consent solicitations (effective 2023-05-18).
  - Change: bylaw amendment
  - Effective: 2023-05-18
  source text: On May 18, 2023, the Board of Directors of Oncotelic Therapeutics, Inc. (the “ Company ”) adopted the new amended and restated by-laws (the “ New By-Laws ”) for the Company, replacing the prior amended and restated by-laws. The New By-Laws contain new provisions for advance notices by shareholders to propose items for consideration at future Annual Meetings or Consent Solicitations.
  evidence_url: https://www.sec.gov/Archives/edgar/data/908259/000149315223018380/0001493152-23-018380-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.